Testing lab
Ethos Analytics certificates of analysis
58 published certificates name Ethos Analytics, from 1 tracked vendor across 17 compounds, dated Apr 9, 2026 to Oct 27, 2026. These are the vendors' own published copies; PeptideAudits doesn't test products. Figures cover only the vendors we track.
How to check a Ethos Analytics report
Ethos Analytics offers a public company + Sample ID lookup (opens the lab's own PDF). Enter the code printed on the seller's certificate on the lab's site and compare the lab's copy with the seller's: compound, lot, date, purity and amount should all match. Reports that print a usable lookup code earn full lab credibility points.
Open the Ethos Analytics lookup How to read a certificate of analysis →- Certificates on file
- 58
- Latest reports used for grades
- 24
- Average reported purity
- 99.00%
- Confirmed on the lab's site
- 57 of 58
58 reports print purity
What these certificates report
- Quantity measured: 58 of 58
- Endotoxin reported: 58 of 58
- Heavy metals reported: 58 of 58
- Sterility reported: 7 of 58
- Microbial screening reported: 58 of 58
Which tests appear depends on what each vendor ordered, not only on the lab. A panel a certificate doesn't mention counts as not reported, never as a pass or a fail.
Vendors publishing Ethos Analytics reports
- Oros Research58 reports
Compounds tested
Newest 30 certificates naming Ethos Analytics
- Oros Research · Retatrutide 20mg99%Oct 27, 202691report
- Oros Research · Retatrutide 10mg99%Oct 27, 202691report
- Oros Research · TB-500 10mg99%Oct 8, 202698report
- Oros Research · Epitalon 10mg99%Oct 8, 202694report
- Oros Research · GHK-Cu 50mg99%Oct 8, 202691report
- Oros Research · BPC-157 10mg99%Oct 8, 202691report
- Oros Research · Tesamorelin 10mg99%Oct 8, 202691report
- Oros Research · MOTS-c 50mg99%Sep 10, 2026100report
- Oros Research · GHK-Cu 100mg99%Sep 10, 202694report
- Oros Research · PT-141 10mg99%Aug 18, 2026100report
- Oros Research · NAD+ 500mg99%Aug 18, 202696report
- Oros Research · Semax 30mg99%Aug 13, 2026100report
- Oros Research · Selank 10mg99%Aug 10, 2026100report
- Oros Research · AOD-9604 5mg99%Jul 26, 202694report
- Oros Research · MOTS-c 20mg99%Jul 26, 202692report
- Oros Research · GHK-Cu 50mg99%Jul 26, 202686report
- Oros Research · CJC-1295 5mg99%Jul 6, 202694report
- Oros Research · TB-500 10mg99%Jul 6, 202692report
- Oros Research · BPC-157 5mg99%Jul 6, 202686report
- Oros Research · PT-141 10mg99%Jul 5, 202694report
- Oros Research · Retatrutide 20mg99%Jun 25, 202680report
- Oros Research · Retatrutide 10mg99%Jun 25, 202680report
- Oros Research · NAD+ 500mg99%Jun 23, 202689report
- Oros Research · Sermorelin 5mg99%Jun 23, 202687report
- Oros Research · Ipamorelin 5mg99%Jun 23, 202687report
- Oros Research · CJC-1295 5mg99%Jun 23, 202687report
- Oros Research · Tesamorelin 10mg99%Jun 23, 202680report
- Oros Research · GHK-Cu 50mg99%Jun 23, 202680report
- Oros Research · KPV 15mg99%Jun 23, 202678report
- Oros Research · MOTS-c 10mg99%Jun 12, 202689report